DEPO-MEDRONE WITH LIDOCAINE Suspension for injection Ref.[50564] Active ingredients: Lidocaine Methylprednisolone

Source: Health Products Regulatory Authority (IE)  Revision Year: 2021  Publisher: Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24, Ireland

Product name and form

Depo-Medrone 40mg/ml with Lidocaine 10mg/ml Suspension for Injection, 1ml vial.

Pharmaceutical Form

Suspension for Injection.

Sterile white aqueous suspension.

Qualitative and quantitative composition

Each ml contains methylprednisolone acetate 40 mg and lidocaine hydrochloride 10 mg.

Each vial contains 40 mg methylprednisolone acetate and 10 mg lidocaine hydrochloride.

Excipient with known effect: Benzyl alcohol: 8.7 mg per ml.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Lidocaine

Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane.

Methylprednisolone

Methylprednisolone is a synthetic glucocorticoid and a methyl derivative of prednisolone. Methylprednisolone is a potent anti-inflammatory agent with the capacity to profoundly inhibit the immune system.

List of Excipients

Macrogol
Sodium chloride
Miripirium chloride
Benzyl alcohol (E1519)
Water for injections
Sodium hydroxide
Hydrochloric acid

Pack sizes and marketing

Type I flint glass vials with a butyl rubber cap. Each vial contains 1 ml of suspension.

Vials packed singly and in 10 vial packs.

Not all pack sizes may be marketed.

Marketing authorization holder

Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24, Ireland

Marketing authorization dates and numbers

PA0822/123/001

Date of first authorisation: 05 July 1983
Date of last renewal: 28 January 2006

Drugs

Drug Countries
DEPO-MEDRONE WITH LIDOCAINE Ireland, United Kingdom, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.